Research method
Biomonitoring
9 studies
Biomonitoring measures a chemical or its metabolite in blood, urine or another tissue as a marker of exposure. Serum PFAS often reflects years of accumulated body burden; a urinary phthalate metabolite reflects recent excretion. Neither result is an absorbed dose by itself: converting a concentration into intake requires toxicokinetics, sampling timing and, for mixtures, a way to uncouple compounds that travel together.
Exposure scientists use biomonitoring to compare contaminated communities, reconstruct sources (drinking water, seafood, carpets, personal-care products) and link internal dose to lipids, blood pressure or metabolic markers. It answers 'how much is in people, and does that internal marker track this physiology?' Its main limitation is that a cross-sectional lipid or blood-pressure association cannot prove later heart disease, highly correlated PFAS cannot be blamed one-by-one, and a spot urine MEP is not proof that a named product delivered that absorbed dose.
Studies
9
Findings
6
7 supporting · 0 challenging · 0 qualifying citations
Open tensions
2
Currently
What we know
- Ronneby drinking-water contamination produced extreme serum PFAS. Among 1,945 adults aged 20–60, exposed sera were dominated by PFOS (median 157 ng/ml) and PFHxS (median 136 ng/ml). Cholesterol and LDL were 7–9% higher than in the control town; odds of high cholesterol were about 1.3 per ln-PFAS unit. PFOS and PFHxS were too correlated (r ≈ 0.9) to separate.
- Veneto youth in a highly exposed drinking-water community had hypertension ORs of 1.06 (PFOA), 1.12 (PFOS) and 1.08 (PFHxS); in men the PFNA OR was 1.19. Absolute blood-pressure shifts were small. The ecological Veneto mortality paper reports a community median serum PFOA of 14 ng/mL — two orders of magnitude below Ronneby's PFOS/PFHxS medians and not an individual-dose analysis.
- NHANES feminine-hygiene data tied douching to urinary MEP. 37% of Black women had douched in the past month versus 14% of White and 10% of Mexican-American women (frequent douching 20% vs 7% and 3%). Past-month douching: 51.6% higher MEP; frequent use: 152.2% higher (dose–response p-trend < 0.001). Other products were not significant.
- In 3,083 nondiabetic NHANES participants aged 12–<80, women had higher creatinine-adjusted phthalates; MnBP, MiBP, MCPP and ΣDEHP associated with diabetes-risk markers. MiBP's top quartile raised median fasting glucose 5.82 mg/dL in Mexican-Americans versus a nonsignificant 1.79 mg/dL in whites — a stratified association, not a universal slope.
- PFAS profiles can separate sources but explain little variance. Faroese whalers' mixes were ~80% PFOS and separated on PC1 (51% of variance); children's profiles were richer in PFHxS and N-EtFOSAA. Hair mercury correlated with PFHpS, PFDA, PFOS and PFUnDA (ρ 0.35–0.61). In NHANES, carpets raised PFHxS 37.2% and seafood tracked PFNA, yet the models explained only 9–25% of PFAS variance.
Largest unresolved question
PFAS biomonitoring is not one concentration or one health claim. Ronneby exposed medians are PFOS 157 ng/ml and PFHxS 136 ng/ml with 7–9% higher cholesterol; Veneto mortality work uses median PFOA 14 ng/mL as an ecological marker; Veneto youth BP ORs sit at 1.06–1.12 with small absolute shifts. Compound, concentration range and endpoint all differ.
Procedure
How it works
The main stages of the method. Specific protocols and analysis choices vary between studies.
Collect blood, urine, or tissue
A biospecimen is taken from people in a community, a survey, or a clinic. Who is sampled — open recruitment, an exposed town, NHANES — is already a filter, not a random draw from everyone who drinks the water.
Quantify the chemical or its metabolite
Serum PFAS often reflects years of accumulated body burden; a urinary phthalate metabolite reflects recent excretion. The laboratory number is a concentration in that matrix, not yet an absorbed dose.
Interpret timing and toxicokinetics
Converting concentration into intake needs kinetics, sampling timing, and creatinine or specific-gravity handling for urine. Highly correlated PFAS cannot be blamed one-by-one; a mixture signal is not a single-compound effect.
Link the marker to a source or a physiology
Papers compare communities, reconstruct drinking water or personal-care sources, or associate the internal marker with lipids, blood pressure, or metabolic indices. A distinctive profile can still be mimicked by toxicokinetics and time trends.
Do not treat the concentration as later disease
Biomonitoring answers how much is in people, and whether that internal marker tracks this physiology. A cross-sectional lipid association cannot prove later heart disease, and a spot urine metabolite is not proof that a named product delivered that absorbed dose.
Common misconceptions
A urinary phthalate metabolite is the absorbed dose of that parent compound.
The concentration is excreted metabolite in a spot sample. Without kinetics, timing and creatinine/specific-gravity handling, it is not intake. Formulations change (2001–2004 NHANES products may differ from today's) and self-reported douching cannot pin a brand.
If PFOS and PFHxS are both high in Ronneby, each compound's lipid association can be read separately.
The two were correlated at r ≈ 0.9, so the ~1.3 odds per ln-PFAS unit is a mixture signal. Open sampling is also not a random population sample, and cross-sectional lipids do not prove later heart disease.
A distinctive serum PFAS profile identifies the source with high certainty.
Whaler profiles were ~80% PFOS and PC1 captured 51% of variance, but NHANES/CHirP models still explained only 9–25% of PFAS variance. Toxicokinetics and time trends can mimic source differences; CHirP detected only four PFASs in >50% of people.
Related
Claim ledger
What the evidence shows
Drawn from 9 studies in this library. Mix labels say which citation roles are present; they are not a strength score. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope.
Ronneby drinking-water contamination produced extreme serum PFAS. Among 1,945 adults aged 20–60, exposed sera were dominated by PFOS (median 157 ng/ml) and PFHxS (median 136 ng/ml). Cholesterol and LDL were 7–9% higher than in the control town; odds of high cholesterol were about 1.3 per ln-PFAS unit. PFOS and PFHxS were too correlated (r ≈ 0.9) to separate.
Veneto youth in a highly exposed drinking-water community had hypertension ORs of 1.06 (PFOA), 1.12 (PFOS) and 1.08 (PFHxS); in men the PFNA OR was 1.19. Absolute blood-pressure shifts were small. The ecological Veneto mortality paper reports a community median serum PFOA of 14 ng/mL — two orders of magnitude below Ronneby's PFOS/PFHxS medians and not an individual-dose analysis.
- PFAS in Veneto youth tracked with higher blood pressure
- PFAS-contaminated water linked to excess Veneto deaths
Study Role Design N Population Outcome PFAS in Veneto youth tracked with higher blood pressure Supports CohortVeneto PFAS health-surveillance cohort linking serum PFAS to BP and hypertension N=16224 · 16,224 adults aged 20–39 recruited; 15,786 in main analyses after exclusions Young adults in Veneto Region exposed via PFAS-contaminated drinking water Blood pressure and hypertension associated with serum PFOA, PFOS, PFHxS, and PFNA PFAS-contaminated water linked to excess Veneto deaths Supports CohortSMR comparison of Veneto PFAS-contaminated Red area mortality vs surrounding provinces N=153525 · Red area population ~153,525 (2020); analyses of 51,621 deaths 1985–2018 Residents of 30 Veneto municipalities with PFAS drinking-water contamination All-cause, CVD, and cancer mortality SMRs after water contamination NHANES feminine-hygiene data tied douching to urinary MEP. 37% of Black women had douched in the past month versus 14% of White and 10% of Mexican-American women (frequent douching 20% vs 7% and 3%). Past-month douching: 51.6% higher MEP; frequent use: 152.2% higher (dose–response p-trend < 0.001). Other products were not significant.
In 3,083 nondiabetic NHANES participants aged 12–<80, women had higher creatinine-adjusted phthalates; MnBP, MiBP, MCPP and ΣDEHP associated with diabetes-risk markers. MiBP's top quartile raised median fasting glucose 5.82 mg/dL in Mexican-Americans versus a nonsignificant 1.79 mg/dL in whites — a stratified association, not a universal slope.
PFAS profiles can separate sources but explain little variance. Faroese whalers' mixes were ~80% PFOS and separated on PC1 (51% of variance); children's profiles were richer in PFHxS and N-EtFOSAA. Hair mercury correlated with PFHpS, PFDA, PFOS and PFUnDA (ρ 0.35–0.61). In NHANES, carpets raised PFHxS 37.2% and seafood tracked PFNA, yet the models explained only 9–25% of PFAS variance.
Among 30 urban and 30 rural premenstrual girls in Gharbiah, Egypt, MEP was highest (urban median 98.8 ng/mL); specific-gravity-adjusted MBzP, MCPP and MiBP were higher in urban girls; MiBP rose with plastic storage and canned food. US NHANES girls had far higher MBzP medians. The sample cannot explain urban–rural breast-cancer differences by phthalates alone.
Debates
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes.
PFAS biomonitoring is not one concentration or one health claim. Ronneby exposed medians are PFOS 157 ng/ml and PFHxS 136 ng/ml with 7–9% higher cholesterol; Veneto mortality work uses median PFOA 14 ng/mL as an ecological marker; Veneto youth BP ORs sit at 1.06–1.12 with small absolute shifts. Compound, concentration range and endpoint all differ.
PFAS biomonitoring is not one concentration or one health claim. Ronneby exposed medians are PFOS 157 ng/ml and PFHxS 136 ng/ml with 7–9% higher cholesterol; Veneto mortality work uses median PFOA 14 ng/mL as an ecological marker; Veneto youth BP ORs sit at 1.06–1.12 with small absolute shifts. Compound, concentration range and endpoint all differ.
- PFAS in Ronneby water tracks higher cholesterol
- PFAS-contaminated water linked to excess Veneto deaths
- PFAS in Veneto youth tracked with higher blood pressure
Study Role Design N Population Outcome PFAS in Ronneby water tracks higher cholesterol Supports Cross-sectionalOpen sampling of Ronneby/Karlshamn adults comparing serum PFAS and lipids by exposure group N=1945 · 1,945 adults aged 20–60 Adults from PFAS-contaminated Ronneby and control Karlshamn, Sweden Serum cholesterol/LDL associated with PFOS and PFHxS PFAS-contaminated water linked to excess Veneto deaths Supports CohortSMR comparison of Veneto PFAS-contaminated Red area mortality vs surrounding provinces N=153525 · Red area population ~153,525 (2020); analyses of 51,621 deaths 1985–2018 Residents of 30 Veneto municipalities with PFAS drinking-water contamination All-cause, CVD, and cancer mortality SMRs after water contamination PFAS in Veneto youth tracked with higher blood pressure Supports CohortVeneto PFAS health-surveillance cohort linking serum PFAS to BP and hypertension N=16224 · 16,224 adults aged 20–39 recruited; 15,786 in main analyses after exclusions Young adults in Veneto Region exposed via PFAS-contaminated drinking water Blood pressure and hypertension associated with serum PFOA, PFOS, PFHxS, and PFNA
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Urinary phthalate papers disagree on what a metabolite gap means. Douching frequency tracks MEP (51.6% and 152.2% higher) as a disparity pathway; HOMA-IR-related associations differ by race/ethnicity (MiBP fasting-glucose 5.82 vs 1.79 mg/dL); Egyptian urban medians do not match US MBzP. Spot urine plus self-report cannot prove a single product brand caused the pattern.
Urinary phthalate papers disagree on what a metabolite gap means. Douching frequency tracks MEP (51.6% and 152.2% higher) as a disparity pathway; HOMA-IR-related associations differ by race/ethnicity (MiBP fasting-glucose 5.82 vs 1.79 mg/dL); Egyptian urban medians do not match US MBzP. Spot urine plus self-report cannot prove a single product brand caused the pattern.
- Douching helps explain MEP disparities
- Phthalates, insulin resistance, and race gaps
- Phthalates in Egyptian premenstrual girls
Study Role Design N Population Outcome Douching helps explain MEP disparities Supports Cross-sectionalNHANES 2001–2004 feminine-hygiene use linked to urinary MEP and MnBP N=739 · Final analytic sample 739 reproductive-aged women (805 with phthalates before race exclusions) Reproductive-aged US women in NHANES 2001–2004 Urinary MEP (and MnBP) associated with douching frequency and race/ethnicity Phthalates, insulin resistance, and race gaps Supports Cross-sectionalNHANES 2001–2008 phthalate metabolites vs fasting glucose/HOMA-IR by sex and race/ethnicity N=3083 · 3,083 nondiabetic participants aged 12–<80 Nondiabetic US NHANES participants Fasting glucose, insulin, and HOMA-IR associated with urinary phthalates Phthalates in Egyptian premenstrual girls Supports Cross-sectionalPilot urinary phthalate comparison of rural vs urban Egyptian girls and NHANES matches N=60 · 30 urban and 30 rural premenstrual girls (mean age 11.5) Premenstrual girls in Gharbiah, Egypt Urinary phthalate metabolites (MEP, MiBP, MBzP) by urbanicity and food-storage practices
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Timeline
How understanding moved
Study years are when the paper was published. Evidence edits are dated changes to this page's claims. Explanations are when PaperFren added a Discovery — not a claim that the science happened that day.
2026
Concept page published
Biomonitoring
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Coverage edits are distinct from reviewed research changes and corrections. Dates record PaperFren updates; study publication dates appear in the timeline.
- Coverage updated · Concept page published
Papers
9 studies in this library bear on Biomonitoring, ordered by citations.
- Short-chain PFAS in US homes
Ultrashort PFAS like TFA now dominate dust, water, and serum in sampled US homes.
- Canadian pregnancy cohort maps POP levels in blood
MIREC found many POPs in maternal plasma but few in cord blood; parity, age, fish, and birthplace predicted levels.
- PFAS in Ronneby water tracks higher cholesterol
Swedish adults on PFAS-contaminated water had 7–9% higher total cholesterol and LDL, with high odds of cholesterol >6.2 mmol/L as PFOS/PFHxS rose.
- Phthalates, insulin resistance, and race gaps
In NHANES 2001–2008, several urinary phthalates tracked higher glucose and HOMA-IR, with stronger signals in Mexican-Americans than whites.
- Douching helps explain MEP disparities
In NHANES 2001–2004, frequent douching associated with 152% higher urinary MEP; Black women douched more and had higher MEP, linking a product-use pathway to exposure disparities.
- Serum PFAS mixes reveal seafood vs product exposure
Long-chain PFCAs mark seafood/whale diets, while PFHxS and N-EtFOSAA mark carpets and consumer products in children.
- PFAS in Veneto youth tracked with higher blood pressure
In 16,224 Veneto adults aged 20–39 exposed via contaminated drinking water, higher serum PFOA, PFOS, and PFHxS associated with hypertension, with the signal concentrated in men.
- PFAS-contaminated water linked to excess Veneto deaths
Residents of 30 Italian municipalities on a PFAS-contaminated aqueduct had about 3,890 extra deaths from 1985–2018, with later kidney- and testicular-cancer signals.
Show 1 more studiesShow fewer studies
- Phthalates in Egyptian premenstrual girls
Egyptian girls had much less MBzP than US girls but several-fold more MiBP, especially with plastic food storage.
Compare studies
Select 2–10 studies. Design and N are labels, not a ranking.
Nothing selected yet.
Questions
What is still open
PFAS biomonitoring is not one concentration or one health claim. Ronneby exposed medians are PFOS 157 ng/ml and PFHxS 136 ng/ml with 7–9% higher cholesterol; Veneto mortality work uses median PFOA 14 ng/mL as an ecological marker; Veneto youth BP ORs sit at 1.06–1.12 with small absolute shifts. Compound, concentration range and endpoint all differ.
Urinary phthalate papers disagree on what a metabolite gap means. Douching frequency tracks MEP (51.6% and 152.2% higher) as a disparity pathway; HOMA-IR-related associations differ by race/ethnicity (MiBP fasting-glucose 5.82 vs 1.79 mg/dL); Egyptian urban medians do not match US MBzP. Spot urine plus self-report cannot prove a single product brand caused the pattern.
Ask PaperFren about Biomonitoring
Study this conceptflashcards and short-answer questions
Ronneby medians were PFOS 157 ng/ml and PFHxS 136 ng/ml; Veneto's ecological marker was median PFOA 14 ng/mL. Why must a student not average those into 'typical PFAS'?
Different compounds, different exposure pathways (firefighting-foam water vs industrial PFOA contamination), and different study designs (individual serum lipids vs municipal SMRs). The numbers are not interchangeable body burdens.
Past-month douching associated with 51.6% higher MEP and frequent use with 152.2% higher MEP. What would you still need to claim that a specific product caused a racial/ethnic exposure disparity?
Product formulation and brand, a design that is not one-spot urine plus self-report, and kinetics linking excreted MEP to absorbed parent. The paper shows a dose–response with douching frequency (p-trend < 0.001), not a causal brand trial.
Why can carpets raising PFHxS 37.2% in NHANES still leave most PFAS variation unexplained?
Measured predictors (seafood, carpets, water) captured only 9–25% of variance. Half-lives, historical production, and unmeasured products remain. A statistically significant source coefficient is not a complete exposure model.
Veneto youth hypertension ORs were 1.06–1.12 with small absolute BP shifts in a highly exposed community. What two cautions follow for a background-level population?
Cross-sectional data cannot prove PFAS caused hypertension, and the community is unusually highly exposed, so the OR may not transport to ordinary serum ranges. Small millimetre BP shifts can still be statistically associated.